Mode
Text Size
Log in / Sign up

Observational study finds 49% AKI incidence in fulminant myocarditis patients, identifies risk factors

Observational study finds 49% AKI incidence in fulminant myocarditis patients, identifies risk facto…
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider male gender, elevated NT-pro BNP/procalcitonin, and low LVEF as potential AKI risk markers in fulminant myocarditis.

This observational cohort study analyzed 408 fulminant myocarditis (FM) patients treated at Central China Fuwai Hospital to identify risk factors for acute kidney injury (AKI) and its progression to chronic kidney disease (CKD). The study compared patients who developed AKI with those who did not. The primary finding was that 201 patients (49.2%) exhibited FM-associated AKI. Risk factors identified through statistical analysis (P < 0.05) included male gender, elevated baseline NT-pro BNP and procalcitonin levels, and reduced left ventricular ejection fraction. Surviving AKI patients were followed for at least 3 months to observe CKD progression, though specific progression rates were not reported. Safety and tolerability data were not reported. The study's key limitations include its observational, single-center design, which can only identify associations rather than establish causation. Specific effect sizes, confidence intervals, and absolute risk increases for the identified factors were not provided, limiting clinical quantification of risk. The authors suggest the findings could inform a risk prediction model to improve renal prognosis in FM patients, but such a model would require external validation. Clinicians should interpret these associations cautiously when assessing individual patient risk.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
ObjectiveThis observational cohort study aimed to identify risk factors for acute kidney injury (AKI) related to fulminant myocarditis (FM) and for the progression of AKI to chronic kidney disease (CKD), as well as to develop a risk prediction model to help improve the renal prognosis in FM patients.MethodsClinical data were collected for FM patients treated at Central China Fuwai Hospital between December 1, 2018 and June 30, 2025. Patients were categorized into AKI and non-AKI groups, and surviving AKI patients were followed for at least 3 months to observe CKD progression. The logistic regression model was used to analyze the risk factors for FM-associated AKI and its progression to CKD. A receiver operator characteristic (ROC) curve was drawn to evaluate the performance of the clinical risk factor model.ResultsOf the 408 FM patients included in this study, 201 (49.2%) exhibited FM-associated AKI. Male gender, elevated baseline N-terminal pro b-type natriuretic peptide (NT-pro BNP) and procalcitonin levels and reduced left ventricular ejection fraction were identified as risk factors for FM-associated AKI (P 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.